Literature DB >> 3156475

Three autopsy cases of progression to left ventricular dilatation in patients with hypertrophic cardiomyopathy.

C Yutani, M Imakita, H Ishibashi-Ueda, K Hatanaka, S Nagata, H Sakakibara, Y Nimura.   

Abstract

The hearts of three cases of congestive heart failure with dilated left ventricles developing in patients with symptomatic hypertrophic cardiomyopathy (HCM) were morphologically investigated. The results showed that disproportionate hypertrophy and dilatation of the left ventricles, accompanied by massive fibrosis and myocardial disarray, were present in the three patients. The mean percent area of fibrosis of the left ventricle was 34.7% and 47.4% at the upper third and lower third levels, respectively, and was much more frequently associated with disarray (84.4 +/- 12.3%). Moreover, the fibrosis was most extensive in the lateral wall of the left ventricle, followed by the posterior, anterior, and interventricular walls. The fibrosis was also diffuse regardless of the subendocardial or subepicardial region of the heart. The findings in the present study suggest that the disarray in this particular series of HCM might be responsible for the mechanism of the fibrosis leading to dilatation of the left ventricle.

Entities:  

Mesh:

Year:  1985        PMID: 3156475     DOI: 10.1016/0002-8703(85)90561-7

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  7 in total

1.  Clinical implications of hypertrophic cardiomyopathy associated with mutations in the alpha-tropomyosin gene.

Authors:  K Yamauchi-Takihara; C Nakajima-Taniguchi; H Matsui; Y Fujio; K Kunisada; S Nagata; T Kishimoto
Journal:  Heart       Date:  1996-07       Impact factor: 5.994

2.  Hypertrophic cardiomyopathy: the interrelation of disarray, fibrosis, and small vessel disease.

Authors:  A M Varnava; P M Elliott; S Sharma; W J McKenna; M J Davies
Journal:  Heart       Date:  2000-11       Impact factor: 5.994

3.  Luminal narrowing of coronary capillaries in human hypertrophic hearts: an ultrastructural morphometrical study using endomyocardial biopsy specimens.

Authors:  G Takemura; Y Takatsu; H Fujiwara
Journal:  Heart       Date:  1998-01       Impact factor: 5.994

4.  Long-term course and cardiac sympathetic nerve activity in patients with hypertrophic cardiomyopathy.

Authors:  M Shimizu; N Sugihara; Y Kita; K Shimizu; Y Horita; K Nakajima; J Taki; R Takeda
Journal:  Br Heart J       Date:  1992-02

5.  Left ventricular chamber dilatation in hypertrophic cardiomyopathy: related variables and prognosis in patients with medical and surgical therapy.

Authors:  C Seiler; R Jenni; G Vassalli; M Turina; O M Hess
Journal:  Br Heart J       Date:  1995-11

6.  Is I-123-beta-methyl-p-iodophenyl-methylpentadecanoic acid imaging useful to evaluate asymptomatic patients with hypertrophic cardiomyopathy? I-123 BMIPP imaging to evaluate asymptomatic hypertrophic cardiomyopathy.

Authors:  Michihiro Narita; Tadashi Kurihara
Journal:  Int J Cardiovasc Imaging       Date:  2003-12       Impact factor: 2.357

7.  Implantation of ventricular assist devices in hypertrophic cardiomyopathy with left ventricular systolic dysfunction.

Authors:  Nobuichiro Yagi; Osamu Seguchi; Hiroki Mochizuki; Kensuke Kuroda; Seiko Nakajima; Takuya Watanabe; Masanobu Yanase; Naoki Tadokoro; Satsuki Fukushima; Tomoyuki Fujita; Norihide Fukushima
Journal:  ESC Heart Fail       Date:  2021-10-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.